InnoCan Pharma
Developing over-the-counter Cannabinoid-based drugs for psoriasis and muscle and joint pains. Learn more
Launch date
Employees
Market cap
CAD68.6m
Enterprise valuation
CAD62m (Public information from Sep 2024)
Share price
CAD0.235 INNO.CN
Tel Aviv-Yafo Tel Aviv District (HQ)
Authorizing premium user...